Innovation thrives on collaboration. As a mission-driven organization dedicated to advancing eye health, we are always seeking ways to support emerging technologies that align with our goals. That’s why we’re proud to partner with Visilant, an innovative startup social enterprise revolutionizing the way artificial intelligence is used in ophthalmology. By investing in its development, we’re not just ensuring collaboration—we’re empowering cutting-edge solutions for the future.
Towards our shared mission, KeraLink has supported Visilant’s groundbreaking work in two key areas:
- Building a database of smartphone-based imaged-data collection to facilitate AI-enabled, accurate, accessible imaged-based diagnostics in ophthalmology.
- Building a Quality Management System (QMS) Infrastructure—ensuring that their innovative products are developed within a regulatory-compliant framework, using Ultralight, an eQMS platform for modern product teams.
Traditionally, implementing a QMS involves hiring expensive consultants and wrestling with cumbersome processes. Most eQMS platforms are also tailored towards traditional hardware products and industry experts. But Ultralight simplifies product development and compliance by providing an intuitive, cost-effective platform that takes into account how modern medical devices—which increasingly include software and algorithmic components as well as cybersecurity requirements—are created and deployed into the world. Designed by a repeat health tech founder alongside a former Facebook engineer, Ultralight combines robust functionality with exceptional user experience (UX)—a rarity in the medical device world, where UX often counterintuitively takes a back seat to compliance requirements.
With Ultralight, companies like Visilant can easily set up and manage a compliant QMS, navigate complex regulatory requirements, and streamline processes to focus on their core innovations.
As a medical device developer, KeraLink International adheres to stringent quality standards to ensure the safety and effectiveness of our products. A critical part of this process is working exclusively with qualified suppliers. For Visilant, which provides AI-driven screening solutions, this means having their own QMS in place.
The partnership between KeraLink International, Visilant, and Ultralight is a perfect example of how startups can support each other in creating transformative solutions. While Visilant focuses on developing cutting-edge imaging and AI technologies, Ultralight ensures that its infrastructure meets the rigorous demands of medical device development. Meanwhile, KeraLink fosters this ecosystem through funding and guidance.
